Document is current
Any future updates will be listed below
-
Authors
Demelash, Robel https://orcid.org/0009-0007-7341-7586
Hailu, Getachew
Abuhay, Taye
Addis, Zemenu
Tega, Ayenew
Nibret, Degarege
Habtu, Yitagesu
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 12 August 2025
First Online: 19 August 2025
Declarations
:
: The authors declare no competing interests.
: Due to the retrospective nature of the study, the need to obtain the informed consent was waived by the Institutional Review Board (IRB) of the College of Health Sciences of Bahir Dar University approved the study, with study protocol number 730/2023. The IRB performs following the Declaration of Helsinki, the International Conferences on Harmonisation (ICH) Good Clinical Practice, the WHO Operating Guidelines for Ethical Review Committee and the National Guideline for Research Ethics in Ethiopia. The Amhara Public Health Institute (APHI) reviewed the ethical approval protocols and requested that the selected hospitals and health centres provide records of TB/HIV treatment follow-up data to the authors. Accordingly, the health facilities’ patient charts or ART follow-up forms were used. The name of the patient was not included in the checklist. The data of any patient were not used for other purposes other than for the aim of this study.
